Drug-induced liver disease.
作者信息
Sumner H W, Holtzman J L, McClain C J
出版信息
Geriatrics. 1981 Oct;36(10):83-96.
PMID:7274672
Abstract
摘要
相似文献
1
Drug-induced liver disease.
Geriatrics. 1981 Oct;36(10):83-96.
2
Drug-induced hepatotoxicity.药物性肝毒性
N Engl J Med. 1995 Oct 26;333(17):1118-27. doi: 10.1056/NEJM199510263331706.
3
[Drug lesions of the liver].[肝脏的药物性损害]
Vutr Boles. 1985;24(6):17-22.
4
Drug-induced liver injury.药物性肝损伤
Neth J Med. 1980;23(1):23-32.
5
Drug-induced liver disease. Foreword.
Semin Liver Dis. 1981 May;1(2):91-2. doi: 10.1055/s-2008-1040721.
6
Drug-induced liver disease: an overview.药物性肝病：概述
Semin Liver Dis. 1981 May;1(2):93-103. doi: 10.1055/s-2008-1040722.
7
An algorithm for monitoring and managing drug hepatotoxicity.一种监测和管理药物肝毒性的算法。
Gastroenterology. 1974 Aug;67(2):309-13.
8
[Hepatitis caused by drugs. I].[药物性肝炎。I]
Rev Esp Enferm Apar Dig. 1982 Jul;62(1):74-82.
9
[Drug-induced hepatopathies].[药物性肝病]
Pol Arch Med Wewn. 1974 May;51(5):519-30.
10
Hepatic injury by prescription medication.
Med Sect Proc. 1983:79-86.
引用本文的文献
1
Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients.奥司他韦治疗对抗凝的影响：华法林抗凝患者的交叉研究。
Br J Clin Pharmacol. 2010 Dec;70(6):834-43. doi: 10.1111/j.1365-2125.2010.03780.x.
2
Optimal delivery of vaccines: clinical pharmacokinetic considerations.疫苗的最佳接种：临床药代动力学考量
Clin Pharmacokinet. 1996 Jan;30(1):1-15. doi: 10.2165/00003088-199630010-00001.
Zotero 插件